Custom synthesis | Naphthyridine | Pyrimidine | Indoline |
Peptides

Enfuvirtide 159519-65-0

Enfuvirtide is indicated for the treatment of HIV-1 infection, in combination therapy with other antiretrovirals, in patients where all other treatments have failed.

Enfuvirtide 159519-65-0
Enfuvirtide 159519-65-0
Appearance:White powder
Cas No:159519-65-0
EINECS:NA
Formula:C204H301N51O64
Molecular Weight:4491.92
Melting Point:NA
Boiling Point:NA
Flash Point: NA
Usage:Polypeptide
Testing Items
Standards:Enterprise
Appearance
White powder
Identification
should conform
Purity NLT95% NLT98%

GMP for Enfuvirtide is not available yet, DMF for Daclatasvir is under preparation

Disclaimer:Those products (Enfuvirtide 159519-65-0) are for lab analytical & research purposes only.